TNF and rheumatoid arthritis: To this end, improved pharmacological therapy for RA, particularly after the introduction of biological medication with anti-TNFa agents, has significantly improved disease management and appears to reduce hospital admissions and lengths of stay [15], but it also increased direct drug costs [2,4,16].